Osteoarthritis (OA) is a common degenerative joint disease that results in severe pain, impaired mobility, and even disability. An increasing body of evidence suggests that improving the dysbiosis of gut microbiota and increasing the content of short-chain fatty acids (SCFAs) can further alleviate clinical symptoms and delay the progression of this disease.
On April 8th, 2024, the Journal of Nanobiotechnology reported that Au nanoparticles can improve excessive bone loss in the development of both osteoporosis (OP) and rheumatoid arthritis (RA) by changing the gut microbiota.
The researchers observed that Au nanoparticles significantly alleviated OA induced by anterior cruciate ligament transection (ACLT) in a gut microbiota-dependent manner. 16S rDNA gene sequencing showed that Au nanoparticles altered the diversity and structure of gut microbiota, manifested as an increase in the abundance of Akkermansia and Lactobacillus.
In addition, Au nanoparticles also increased the content of SCFAs, such as butyrate, which can improve bone destruction by reducing inflammation. It is worth noting that Au nanoparticles regulated the dynamic balance of M1/M2 macrophages and increased the serum level of anti-inflammatory cytokines, such as IL-10.
This study demonstrates that Au nanoparticles exert an anti-osteoarthritis effect by regulating the interaction between the "microbiota-gut-joint" axis, providing a promising approach for the treatment of osteoarthritis.
The "Microbiota-Gut-Joint" Axis
The "microbiota-gut-joint" axis is a communication pathway linking the gut microbiota, the intestinal immune system, and joint tissues. The gut microbiota plays a key role in maintaining the homeostasis of the host immune system and the metabolism of nutrients.
However, this balance can be disturbed by various factors, such as antibiotics, stress, and dietary changes, leading to dysbiosis of gut microbiota, intestinal inflammation, and increased intestinal permeability. As a result, microbial metabolites, such as lipopolysaccharides (LPS), can enter the circulation and activate innate immunity, leading to systemic inflammation and joint damage.
Au Nanoparticles and Gut Microbiota
Au nanoparticles have been widely used in biomedical research due to their unique physicochemical properties, such as small size, high surface area, and biocompatibility. Previous studies have demonstrated that Au nanoparticles can interact with biomolecules, such as DNA, RNA, proteins, and enzymes, and regulate cellular processes, such as cell proliferation, apoptosis, and differentiation.
In recent years, the application of Au nanoparticles in gut microbiota research has also received widespread attention. It has been reported that Au nanoparticles can modulate the composition and function of gut microbiota and improve intestinal inflammation and barrier function.
Au Nanoparticles and SCFAs
SCFAs, including acetate, propionate, and butyrate, are the major microbial metabolites produced by the fermentation of dietary fiber in the colon. SCFAs play a key role in regulating the metabolism and immune function of the host by binding to specific receptors, such as GPR41 and GPR43.
Previous studies have shown that butyrate can inhibit the differentiation of osteoclasts and promote the differentiation of osteoblasts, leading to reduced bone destruction. In addition, SCFAs can also modulate the differentiation and function of immune cells, such as macrophages, T cells, and regulatory T cells (Tregs), and regulate the balance between inflammation and tolerance.
In summary, the study described the potential application of Au nanoparticles in regulating the "microbiota-gut-joint" axis to exert anti-osteoarthritis effects. Future studies should focus on the safety and efficacy of Au nanoparticles and their clinical applications.
SAT NANO is a best supplier of gold nanoparticle in China, we can offer 20-30nm, 50nm, 100nm with 99.99%, if you have any enquiry, please feel free to contact us at sales03@satnano.com
